Cardiawave

cardiawave.com

Cardiawave has developed a unique non-invasive ultrasound therapy for the treatment of calcific aortic stenosis, aiming to improve patient care quality. Their innovative approach repairs the aortic valve without surgery, addressing a significant unmet medical need in a market where 65% of severe symptomatic aortic stenosis patients remain untreated. With a focus on non-invasive therapies, Cardiawave is positioned to capture a share of the $5.6 billion health spending in the U.S. for symptomatic aortic valve disease, leveraging cutting-edge technology and strong backing from European funding programs.